These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28017438)

  • 1. The role of vaccines and vaccine decision-making to achieve the goals of the Grand Convergence in public health.
    Kaslow DC; Kalil J; Bloom D; Breghi G; Colucci AM; De Gregorio E; Madhavan G; Meier G; Seabrook R; Xu X
    Vaccine; 2017 Jan; 35 Suppl 1():A10-A15. PubMed ID: 28017438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicriteria decision analysis and core values for enhancing vaccine-related decision-making.
    Barocchi MA; Black S; Rappuoli R
    Sci Transl Med; 2016 Jun; 8(345):345ps14. PubMed ID: 27358496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
    Knobler S; Bok K; Gellin B
    Vaccine; 2017 Jan; 35 Suppl 1():A43-A45. PubMed ID: 28017435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core values for vaccine evaluation.
    Timmis JK; Rigat F; Rappuoli R
    Vaccine; 2017 Jan; 35 Suppl 1():A57-A62. PubMed ID: 28017445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prioritizing vaccines for developing world diseases.
    Saul A; O'Brien KL
    Vaccine; 2017 Jan; 35 Suppl 1():A16-A19. PubMed ID: 28017442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What drivers will influence global immunizations in the era of grand convergence in global health?
    Levine OS
    Vaccine; 2017 Jan; 35 Suppl 1(Suppl 1):A6-A9. PubMed ID: 28017439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the vaccines industry in Mission Grand Convergence.
    Almond J; Medaglini D
    Vaccine; 2017 Jan; 35 Suppl 1():A24-A28. PubMed ID: 28017440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two decades of vaccine innovations for global public good: Report of the Developing Countries' Vaccine Manufacturers Network 20th meeting, 21-23 october 2019, Rio de Janeiro, Brazil.
    Pagliusi S; Dennehy M; Homma A
    Vaccine; 2020 Aug; 38(36):5851-5860. PubMed ID: 32535016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving accountability in vaccine decision-making.
    Timmis JK; Black S; Rappuoli R
    Expert Rev Vaccines; 2017 Nov; 16(11):1057-1066. PubMed ID: 28929818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the full public health value of vaccination.
    Gessner BD; Kaslow D; Louis J; Neuzil K; O'Brien KL; Picot V; Pang T; Parashar UD; Saadatian-Elahi M; Nelson CB
    Vaccine; 2017 Nov; 35(46):6255-6263. PubMed ID: 28986035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving a "Grand Convergence" in global health by 2035.
    Mahmoud A
    Vaccine; 2017 Jan; 35 Suppl 1():A2-A5. PubMed ID: 28012780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What criteria do decision makers in Thailand use to set priorities for vaccine introduction?
    Pooripussarakul S; Riewpaiboon A; Bishai D; Muangchana C; Tantivess S
    BMC Public Health; 2016 Aug; 16():684. PubMed ID: 27484123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Grand Convergence: Closing the Divide between Public Health Funding and Global Health Needs.
    Moran M
    PLoS Biol; 2016 Mar; 14(3):e1002363. PubMed ID: 26933890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-criteria decision analysis to prioritize the introduction of new vaccines in Indonesia by using the framework of the strategic multi-attribute ranking tool for vaccines (SMART vaccines).
    Suwantika AA; Purwadi FV; Zakiyah N; Puspitasari IM; Abdulah R; Diantini A; Boersma C; Postma MJ
    Expert Rev Vaccines; 2021 Jan; 20(1):83-91. PubMed ID: 33428502
    [No Abstract]   [Full Text] [Related]  

  • 18. The public health value of vaccines beyond efficacy: methods, measures and outcomes.
    Wilder-Smith A; Longini I; Zuber PL; Bärnighausen T; Edmunds WJ; Dean N; Spicher VM; Benissa MR; Gessner BD
    BMC Med; 2017 Jul; 15(1):138. PubMed ID: 28743299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Path to impact: A report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin - January 29-30, 2015.
    Sobanjo-Ter Meulen A; Abramson J; Mason E; Rees H; Schwalbe N; Bergquist S; Klugman KP
    Vaccine; 2015 Nov; 33(47):6388-95. PubMed ID: 26314626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strengthening global vaccine access for adolescents and adults.
    Nanni A; Meredith S; Gati S; Holm K; Harmon T; Ginsberg A
    Vaccine; 2017 Dec; 35(49 Pt B):6823-6827. PubMed ID: 29122384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.